Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Neoplasms × Cholecystectomy × Clear all

Phase

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 1 Cachexia 1

Interventions

Gemcitabine 29 pembrolizumab 22 Cyclophosphamide 20 Paclitaxel 17 Irinotecan 17 Carboplatin 17 Fluorouracil 16 Docetaxel 16 Capecitabine 16 Leucovorin 13 fludarabine 12 Bevacizumab 12 Oxaliplatin 11 Everolimus 11 Dexamethasone 11 Rituximab 10 Pemetrexed 10 Erlotinib Hydrochloride 10 Blood Specimen Collection 10 Cisplatin 9 venetoclax 8 Cetuximab 8 Trastuzumab 7 Nivolumab 7 aldesleukin 6 Temozolomide 6 Sunitinib 6 Ipilimumab 6 Interleukin-2 6 Epoetin Alfa 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05128318 2024-05-09

TuLip

Université Catholique de Louvain

Phase NA Terminated

Cachexia, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡